跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pfizer (Australia) METHOTREXATE 500mg/20mL injection BP vial - TGA Drug Approval Details
Approvals
/
TGA
/
Pfizer (Australia) METHOTREXATE 500mg/20mL injection BP vial
Approved
STANDARD
Pfizer (Australia) METHOTREXATE 500mg/20mL injection BP vial
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
dfd86f1cfc5411c9
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
dfd86f1cfc5411c9
Product Name
Pfizer (Australia) METHOTREXATE 500mg/20mL injection BP vial
Artg Id
47648
Artg Name
Pfizer (Australia) METHOTREXATE 500mg/20mL injection BP vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1994-01-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
dfd86f1cfc5411c9
Type
Standard
Back to TGA Approvals
